RECRUITING

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across 3 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging. Primary endpoint: Operative time of surgical procedure. Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins. Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.

Official Title

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Quick Facts

Study Start:2024-03-01
Study Completion:2025-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06387485

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Subjects must be at least 22 years of age.
  2. 2. Subjects must have the ability to provide written informed consent.
  3. 3. Subjects must have tumor(s) invading bone and requiring surgical excision including but not limited to craniomaxillofacial, spine, long bone, and pelvis.
  4. 4. Subjects must be willing to have quality cross-sectional imaging that will allow for use to develop a 3D printed model.
  1. 1. Pregnant or nursing women.
  2. 2. Subjects that have a serious systemic pathology.
  3. 3. Subjects that have clotting disorders.
  4. 4. Subjects that have uncontrolled hypertension.
  5. 5. Subjects that are HIV-positive.
  6. 6. Subjects that are unable to be randomized; i.e surgical team prefers to use either 3D model or standard cross-sectional imaging for surgical pre-planning.
  7. 7. Subject anatomy has changed substantially since the date medical imaging from which the model is derived was obtained (as applicable).
  8. 8. Subject is a poor surgical or poor study candidate which may include, any medical, social or psychological problem that could complicate the procedure.

Contacts and Locations

Study Contact

Alexandra Gormley, PhD
CONTACT
484-501-0588
alexandra.gormley@ricoh-usa.com

Study Locations (Sites)

William Beaumont University Hospital
Royal Oak, Michigan, 48073
United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43212
United States

Collaborators and Investigators

Sponsor: Ricoh USA, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-01
Study Completion Date2025-04-01

Study Record Updates

Study Start Date2024-03-01
Study Completion Date2025-04-01

Terms related to this study

Keywords Provided by Researchers

  • bony tumor

Additional Relevant MeSH Terms

  • Sarcoma, Ewing
  • Chondrosarcoma
  • Osteosarcoma
  • Fibrous Histiocytoma
  • Fibrosarcoma